To further elucidate the immune landscape functionally linked to the IL-33 expressing environment, we conducted an immunohistochemistry (IHC) study targeting eosinophils in human prostate tumors characterized by high and low IL-33 content. Here, IL33 is linked to prostate neoplasm.